Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wu Xiaobin, holds the title of President and COO at BeOne Medicines Ltd..
On 2026-08-25, the insider transacted 280 shares.The price in this filing could not be confirmed (company reports from abroad; currency could not be checked), so no dollar value is shown. The SEC filing has the figures as filed.
Wu Xiaobin (President and COO) sold shares of $ONC (value not verified)
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.